Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3600949

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL3600949
Phase Preclinical
Structure Type BOTH
InChI Key DLPKFEIHGKNISM-BZZBYGRJSA-N
2
Targets
19
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names

Molecular Properties

4213.7
MW (Da)

Drug Information

Molecule Type Protein
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C185H291N55O58
MW 4213.69

Activity Summary

IC50 19 meas. best 9.47

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Envelope glycoprotein gp160
CHEMBL3520
 IC50 9.47 8.29 0.3 2
Human immunodeficiency virus 1
CHEMBL378
 IC50 9.32 8.8241 0.5 17

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Envelope glycoprotein gp160 IC50 = 0.34 nM 9.47 Inhibition of HIV-1 HXB2 gp41 N-terminal heptad repeat-mediated fusion between i... 26256053
Human immunodeficiency virus 1 IC50 = 0.48 nM 9.32 Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells a... 26256053
Human immunodeficiency virus 1 IC50 = 0.6 nM 9.22 Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal he... 26256053
Human immunodeficiency virus 1 IC50 = 0.73 nM 9.14 Antiviral activity against HIV-1 ZM214M.15 pseudovirus infected in human TZM-bl ... 26256053
Human immunodeficiency virus 1 IC50 = 1.0 nM 9.0 Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal he... 26256053
Human immunodeficiency virus 1 IC50 = 1.07 nM 8.97 Antiviral activity against HIV1 NL4-3 pseudovirus infected in human TZM-bl cells... 26256053
Human immunodeficiency virus 1 IC50 = 1.1 nM 8.96 Antiviral activity against wild type HIV1 NL4-3 infected in human TZM-bl cells a... 26256053
Human immunodeficiency virus 1 IC50 = 1.2 nM 8.92 Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal he... 26256053
Human immunodeficiency virus 1 IC50 = 1.34 nM 8.87 Antiviral activity against wild type HIV-1 26256053
Human immunodeficiency virus 1 IC50 = 1.4 nM 8.85 Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal he... 26256053
Human immunodeficiency virus 1 IC50 = 1.67 nM 8.78 Antiviral activity against HIV-1 SC42261.8 pseudovirus infected in human TZM-bl ... 26256053
Human immunodeficiency virus 1 IC50 = 1.7 nM 8.77 Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal he... 26256053
Human immunodeficiency virus 1 IC50 = 1.9 nM 8.72 Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal he... 26256053
Human immunodeficiency virus 1 IC50 = 1.9 nM 8.72 Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal he... 26256053
Human immunodeficiency virus 1 IC50 = 2.0 nM 8.7 Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal he... 26256053
Human immunodeficiency virus 1 IC50 = 2.1 nM 8.68 Antiviral activity against ENF-resistant HIV1 NL4-3 harboring gp41 N-terminal he... 26256053
Human immunodeficiency virus 1 IC50 = 5.75 nM 8.24 Antiviral activity against HIV-1 SF162 pseudovirus infected in human TZM-bl cell... 26256053
Human immunodeficiency virus 1 IC50 = 7.0 nM 8.15 Antiviral activity against HIV-1 pseudovirus harboring Q66R/N126K double mutant 26256053
Envelope glycoprotein gp160 IC50 = 77.4 nM 7.11 Binding affinity to HIV-1 HXB2 gp41 N-terminal heptad repeat assessed as inhibit... 26256053

Literature References

PubMed DOI Target Context # Activities
26256053 10.1021/acs.jmedchem.5b00109 Human immunodeficiency virus 1 26
26256053 10.1021/acs.jmedchem.5b00109 Envelope glycoprotein gp160 11
26256053 10.1021/acs.jmedchem.5b00109 No relevant target 1
26256053 10.1021/acs.jmedchem.5b00109 Serum 1

Data from ChEMBL 36 via Core Engine